ArticleObesity science & practice2026
Outcomes and Predictors of Success for Very Low Calorie Diets in an Australian Publicly Funded Bariatric Medicine Service.
Article in Obesity science & practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Enablers of successful completion and outcomes from Very Low Calorie Diets (VLCD) conducted in real-life clinical settings are poorly understood. This study explored weight and metabolic changes following VLCD and identified baseline factors associated with VLCD completion, weight-loss, and weight-loss maintenance. Methods: A retrospective chart review was conducted for patients beginning VLCD between February 1, 2018 and October 31, 2020 at an Australian bariatric medicine service. Univariate analyses assessed weight, glycemic control, blood pressure, and cholesterol changes following 6 and 12 weeks of VLCD. Multivariate analyses explored factors predicting clinically significant weight-loss (CWL), VLCD completion and weight-loss maintenance. Results: The 90 patients who completed VLCD had statistically significant improvements in mean weight and percentage weight lost, blood pressure, glycemic and cholesterol control at 6 (all Conclusions: Weight promoting medications may hinder VLCD completion. OSA and depression have the potential to impede weight-loss from VLCD. Addressing these factors before starting VLCD may enable better adherence and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.